Carolina Romero
@carito_rom
Followers
204
Following
2K
Statuses
6K
RT @NEJM: Internal Medicine rounds are never “aggressively boring” with Dr. G. Watch the latest video in which @DGlaucomflecken summarizes…
0
97
0
RT @geltamo: 📢¡Atención! @GELTAMO ha publicado su Guía de manejo de Anticuerpos Biespecíficos en #LinfomasNoHodgkinB. Ya está disponible pa…
0
37
0
RT @DrRaulCordoba: #Hematology How I treat older patients with relapsed/refractory diffuse large B-cell #lymphoma | @BloodJournal | Ameri…
0
18
0
RT @EHA_Hematology: To kick off the year, we wanted to share a collection of previous #ThinkingThursday posts! We hope you enjoy this selec…
0
18
0
RT @AhmedKo45911157: 🧬Updated #AML Classifications: Genomics & Therapy 🔹ELN 2022(Intensive Therapy): Favorable:t(8;21), inv(16), Mutated NP…
0
21
0
RT @SujayRainchwar: Approach to interpretation of coagulation tests in the presence of DOAC / Newer anticoagulants (though they are no more…
0
5
0
RT @BloodJournal: 📣 Top 10 most read articles of the year published in Blood! 🏆 #BloodJournals
0
23
0
RT @smbenlazar: Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review…
0
55
0
RT @BloodJournal: Primary large B-cell lymphomas of immune-privileged sites #lymphoidneoplasia
0
29
0
RT @AhmedKo45911157: 🩸 LGL Leukemia: Rare clonal disorder with autoimmune ties ➡️ Diagnosis ⚠️ Spectrum: Polyclonal → Aggressive leukemi…
0
16
0
RT @SochinfOficial: El Dr. Marcelo Wolff Reyes hoy recibe en una emotiva ceremonia la distinción de profesor emérito de la Universidad de C…
0
4
0
RT @glimelius: #ASH24 highlights Jennifer Tovbridge - CLL first line, #AMPLIFY, favors Acala+Ven+ Obi vs chemo and Acala + Ven - MCL first…
0
3
0
RT @AhmedKo45911157: Advancing treatment for aggressive cutaneous T-cell lymphomas: 🔹 Advanced MF/SS: compartment-based therapies & cellula…
0
9
0
RT @laura_korin: Great advice shared during the @WomenInLymphoma breakfast at #ASH24. -Small actions can make a big difference. -Don't be…
0
3
0
RT @Fer_martinmoro: Don’t miss today our poster (abstract 4478) about the Spanish @geltamo experience on plasmablastic and primary effusion…
0
8
0
RT @ASH_hematology: The late-breaking abstracts — substantive, novel, and groundbreaking #hematology data that were not available by the g…
0
8
0